Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bar-Or

Showing results (101-110 of 410) with videos related to

Pageof 41
Sort By:
Frontiers in Neurology|March 17, 2022
Vaccine Response in Patients With Multiple Sclerosis Receiving TeriflunomideCarlo Tornatore, Heinz Wiendl, Alex L Lublin, et al.
Neurology|August 22, 2014
Rasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?Dina Amrom, Demet Kinay, Yvonne Hart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosisMartin Duddy, Masaaki Niino, Femina Adatia, et al.
Frontiers in Genetics|January 25, 2013
MicroRNA dysregulation in multiple sclerosisOmar de Faria, Craig S Moore, Timothy E Kennedy, et al.
Blood|June 24, 2006
Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptaseLynette M Kilpatrick, Roger L Harris, Kate A Owen, et al.
Annals of Neurology|October 13, 2007
Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetesBrenda Banwell, Amit Bar-Or, Roy Cheung, et al.
Therapeutic Advances in Neurological Disorders|May 20, 2020
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSERalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Pediatric Neurology|April 25, 2026
Factors Influencing Early and Late B-Cell Repopulation After Rituximab Therapy in Pediatric Central Nervous System Inflammatory DisordersAmaar Marefi, Eleonora A Grasso, Lisa Garber, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2022
The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parentsJulia O'Mahony, Brenda Banwell, Audrey Laporte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2011
Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patientsTrina A Johnson, Barbara L Evans, Bryce A Durafourt, et al.
Pageof 41

Showing results (101-110 of 410) with videos related to

Sort By:
Pageof 41
Frontiers in Neurology|March 17, 2022
Vaccine Response in Patients With Multiple Sclerosis Receiving TeriflunomideCarlo Tornatore, Heinz Wiendl, Alex L Lublin, et al.
Neurology|August 22, 2014
Rasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?Dina Amrom, Demet Kinay, Yvonne Hart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosisMartin Duddy, Masaaki Niino, Femina Adatia, et al.
Frontiers in Genetics|January 25, 2013
MicroRNA dysregulation in multiple sclerosisOmar de Faria, Craig S Moore, Timothy E Kennedy, et al.
Blood|June 24, 2006
Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptaseLynette M Kilpatrick, Roger L Harris, Kate A Owen, et al.
Annals of Neurology|October 13, 2007
Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetesBrenda Banwell, Amit Bar-Or, Roy Cheung, et al.
Therapeutic Advances in Neurological Disorders|May 20, 2020
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSERalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Pediatric Neurology|April 25, 2026
Factors Influencing Early and Late B-Cell Repopulation After Rituximab Therapy in Pediatric Central Nervous System Inflammatory DisordersAmaar Marefi, Eleonora A Grasso, Lisa Garber, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2022
The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parentsJulia O'Mahony, Brenda Banwell, Audrey Laporte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2011
Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patientsTrina A Johnson, Barbara L Evans, Bryce A Durafourt, et al.
Pageof 41